NEW YORK (GenomeWeb News) — GenoLogics today said it has struck an agreement with London Genetics to pursue new collaborative commercial opportunities.
Under the agreement, GenoLogics, headquartered in Victoria, BC, will help promote London Genetics’ efforts to develop a research network including scientists and clinicians, and will provide complementary “advice and expertise” on lab informatics infrastructure and network management to London Genetics’ partners.
The companies will also pursue collaborative partnerships and grant funding.
Through partnerships with UK institutions, London Genetics, based in London, offers access to “clinical and population cohorts, tissue banks, ‘omics software and technologies, as well as access to key opinion leaders from multiple disciplines and therapeutic areas.”
London Genetics partners include Imperial College London and St George’s; the University of London; the Institute of Cancer Research; King’s College London; the London School of Hygiene and Tropical Medicine; Queen Mary; the University of London; and University College London.
Meantime, services GenoLogics will contribute to the partnership include use of its OMIX lab informatics platform and Proteus and Geneus, its related proteomics and genomics modules, as well as a common database for all consortia partners, the company said.